The historical rank and industry rank for Scivision Biotech's OCF Margin % or its related term are showing as below:
TPE:1786'
s OCF Margin % Range Over the Past 10 Years
Min: 6.18 Med: 28.82 Max: 46.68
Current: 13.98
During the past 13 years, the highest OCF Margin % of Scivision Biotech was 46.68%. The lowest was 6.18%. And the median was 28.82%.
TPE:1786's OCF Margin % is ranked better than 67.16% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 5.84
vs TPE:1786: 13.98
Scivision Biotech OCF Margin % Related Terms
Scivision Biotech OCF Margin % Historical Data
* Premium members only.
The historical data trend for Scivision Biotech's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1786 vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Scivision Biotech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scivision Biotech OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Scivision Biotech's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Scivision Biotech's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scivision Biotech (TPE:1786) has a OCF Margin % of -5.18% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Scivision Biotech and its competitors. Over the past decade, Scivision Biotech's OCF Margin % has ranged from 6.18 to 46.68. According to the industry distribution chart, Scivision Biotech ranks #268 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 32.8%.
Is Scivision Biotech's OCF Margin % too high?
Scivision Biotech's current OCF Margin % is -5.18%. Over the past 10 years, this metric has ranged from a low of 6.18 to a high of 46.68. Based on the distribution chart, Scivision Biotech ranks #268 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Scivision Biotech has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Scivision Biotech's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Scivision Biotech ranks #268 out of 816 companies for OCF Margin %. This puts Scivision Biotech in the upper half of its industry. The industry median OCF Margin % is 5.84. Historically, Scivision Biotech's own OCF Margin % has ranged from 6.18 to 46.68 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Scivision Biotech and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scivision Biotech's current OCF Margin % is -5.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scivision Biotech stock overvalued right now?
Based on GuruFocus' analysis, Scivision Biotech (TPE:1786) is currently considered Possible Value Trap. The stock's GF Value™ is NT$115.23, compared to a current price of NT$53.50 — trading 53.6% below its estimated fair value. The current OCF Margin % is -5.18%. Scivision Biotech's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Scivision Biotech (TPE:1786), the current OCF Margin % is -5.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scivision Biotech (TPE:1786) Overvalued in 2026?
Based on GuruFocus' analysis, Scivision Biotech stock appears to be undervalued.
The current stock price of NT$53.50 is trading 53.6% below its estimated GF Value™ of NT$115.23.
GuruFocus considers Scivision Biotech to be Possible Value Trap.
Key valuation signals for TPE:1786:
OCF Margin %: -5.18%
GF Value™: NT$115.23 vs. price of NT$53.50 (53.6% below fair value)
No single metric tells the full story. See the TPE:1786 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.
80GF Score
Get the complete analysis for TPE:1786
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1786 has been successfully added to your 
